NCT06282874 2026-04-09
Lorlatinib in Patients With ALK-Positive NSCLC With Brain or Leptomeningeal Metastases
Guangdong Association of Clinical Trials
Phase 4 Active not recruiting
Guangdong Association of Clinical Trials
Kaohsiung Medical University Chung-Ho Memorial Hospital
Dartmouth-Hitchcock Medical Center